Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Requirement for sphingosine kinase 1 in mediating phase 1 of the hypotensive response to anandamide in the anaesthetised mouse.

Greig FH, Nather K, Ballantyne MD, Kazi ZH, Alganga H, Ewart MA, Zaborska KE, Fertig B, Pyne NJ, Pyne S, Kennedy S.

Eur J Pharmacol. 2019 Jan 5;842:1-9. doi: 10.1016/j.ejphar.2018.10.027. Epub 2018 Oct 23.

2.

PEA-15 (Phosphoprotein Enriched in Astrocytes 15) Is a Protective Mediator in the Vasculature and Is Regulated During Neointimal Hyperplasia.

Greig FH, Kennedy S, Gibson G, Ramos JW, Nixon GF.

J Am Heart Assoc. 2017 Sep 11;6(9). pii: e006936. doi: 10.1161/JAHA.117.006936.

3.

The hypotensive effect of acute and chronic AMP-activated protein kinase activation in normal and hyperlipidemic mice.

Greig FH, Ewart MA, McNaughton E, Cooney J, Spickett CM, Kennedy S.

Vascul Pharmacol. 2015 Nov;74:93-102. doi: 10.1016/j.vph.2015.07.010. Epub 2015 Jul 18.

4.

Differential effects of chlorinated and oxidized phospholipids in vascular tissue: implications for neointima formation.

Greig FH, Hutchison L, Spickett CM, Kennedy S.

Clin Sci (Lond). 2015 May;128(9):579-92. doi: 10.1042/CS20140578.

PMID:
25524654
5.

Phosphoprotein enriched in astrocytes (PEA)-15: a potential therapeutic target in multiple disease states.

Greig FH, Nixon GF.

Pharmacol Ther. 2014 Sep;143(3):265-74. doi: 10.1016/j.pharmthera.2014.03.006. Epub 2014 Mar 20. Review.

6.

Characteristics of diabetes after pediatric liver transplant.

Greig F, Rapaport R, Klein G, Akler G, Annunziato R, Miloh T, Arnon R, Florman S, Kerkar N.

Pediatr Transplant. 2013 Feb;17(1):27-33. doi: 10.1111/j.1399-3046.2012.01779.x. Epub 2012 Aug 20.

PMID:
22905982
7.

The effect of reactive oxygen species on whole blood aggregation and the endothelial cell-platelet interaction in patients with coronary heart disease.

Watt J, Ewart MA, Greig FH, Oldroyd KG, Wadsworth RM, Kennedy S.

Thromb Res. 2012 Aug;130(2):210-5. doi: 10.1016/j.thromres.2012.03.024. Epub 2012 Apr 19.

8.

Risk factors for medication-induced diabetes mellitus.

Regelmann MO, Greig F, Kerkar N, Rapaport R.

J Pediatr. 2012 Feb;160(2):355; author reply 356. doi: 10.1016/j.jpeds.2011.11.001. No abstract available.

PMID:
22240046
9.

Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case-matched observational study.

Goodhand JR, Greig FI, Koodun Y, McDermott A, Wahed M, Langmead L, Rampton DS.

Inflamm Bowel Dis. 2012 Jul;18(7):1232-9. doi: 10.1002/ibd.21846.

PMID:
22234954
10.

Physiological effects of oxidized phospholipids and their cellular signaling mechanisms in inflammation.

Greig FH, Kennedy S, Spickett CM.

Free Radic Biol Med. 2012 Jan 15;52(2):266-80. doi: 10.1016/j.freeradbiomed.2011.10.481. Epub 2011 Oct 31. Review.

PMID:
22080084
11.

Which obese youth are at increased risk for type 2 diabetes? Latent class analysis and comparison with diabetic youth.

Greig F, Hyman S, Wallach E, Hildebrandt T, Rapaport R.

Pediatr Diabetes. 2012 Mar;13(2):181-8. doi: 10.1111/j.1399-5448.2011.00792.x. Epub 2011 Nov 3.

PMID:
22050535
12.

The development of research tools used in the STORK Study (the Scottish Trial of Refer or Keep) to explore midwives' intrapartum decision making.

Styles M, Cheyne H, O'Carroll R, Greig F, Dagge-Bell F, Niven C.

Midwifery. 2011 Oct;27(5):576-81. doi: 10.1016/j.midw.2010.05.011. Epub 2011 Jan 14.

PMID:
21237540
13.

Time for thyrotropin releasing hormone to return to the United States of America.

Rapaport R, Akler G, Regelmann MO, Greig F.

Thyroid. 2010 Sep;20(9):947-8. doi: 10.1089/thy.2010.1656. No abstract available.

PMID:
20825297
14.

Effect of phosphatidylcholine chlorohydrins on human erythrocytes.

Robaszkiewicz A, Greig FH, Pitt AR, Spickett CM, Bartosz G, Soszyński M.

Chem Phys Lipids. 2010 Sep;163(7):639-47. doi: 10.1016/j.chemphyslip.2010.05.201. Epub 2010 Jun 1.

PMID:
20513376
15.

The Scottish Trial of Refer or Keep (the STORK study): midwives' intrapartum decision making.

Styles M, Cheyne H, O'Carroll R, Greig F, Dagge-Bell F, Niven C.

Midwifery. 2011 Feb;27(1):104-11. doi: 10.1016/j.midw.2009.12.003.

PMID:
20137838
16.

Setting priorities for safe motherhood interventions in resource-scarce settings.

Prata N, Sreenivas A, Greig F, Walsh J, Potts M.

Health Policy. 2010 Jan;94(1):1-13. doi: 10.1016/j.healthpol.2009.08.012. Epub 2009 Sep 20. Review.

PMID:
19773090
17.

Late rise of thyroid stimulating hormone in ill newborns.

Hyman SJ, Greig F, Holzman I, Patel A, Wallach E, Rapaport R.

J Pediatr Endocrinol Metab. 2007 Apr;20(4):501-10.

PMID:
17550214
18.

Ability to pay for maternal health services: what will it take to meet who standards?

Prata N, Greig F, Walsh J, West A.

Health Policy. 2004 Nov;70(2):163-74.

PMID:
15364146
20.

Diabetes mellitus: type 1 or type 2?

Rapaport R, Wallach E, Greig F, Iazzetti L.

J Pediatr. 2001 Apr;138(4):612-3. No abstract available.

PMID:
11295742
21.
22.

Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis.

Hou WS, Brömme D, Zhao Y, Mehler E, Dushey C, Weinstein H, Miranda CS, Fraga C, Greig F, Carey J, Rimoin DL, Desnick RJ, Gelb BD.

J Clin Invest. 1999 Mar;103(5):731-8.

23.

Increase in bone density and plasma osteocalcin during growth hormone therapy in growth hormone deficient children.

Greig F, Greenfield E, Prasad V, AvRushkin TW, Bastian W, Yasumura S, Castells S.

J Pediatr Endocrinol Metab. 1997 Jan-Feb;10(1):11-7.

PMID:
9364337
24.

Anti-islet autoantibodies detected by monoclonal antibody 1A2: further studies suggesting a role in the pathogenesis of IDDM.

McEvoy RC, Thomas NM, Greig F, Larson S, Vargas-Rodriguez I, Felix I, Wallach E, Rubinstein P, Goetz FC, Ginsberg-Fellner F.

Diabetologia. 1996 Nov;39(11):1365-71.

PMID:
8933006
25.

Transient congenital hypoparathyroidism: resolution and recurrence in chromosome 22q11 deletion.

Greig F, Paul E, DiMartino-Nardi J, Saenger P.

J Pediatr. 1996 Apr;128(4):563-7.

PMID:
8618195
26.

Both glucagon excess and insulin deficiency characterize maturity-onset diabetes mellitus of youth (MODY).

AvRuskin TW, Obilessetty V, Jabbar M, Prasad V, Greenfield E, Greig F, Juan CS.

J Pediatr Endocrinol. 1994 Oct-Dec;7(4):335-41. No abstract available.

PMID:
7735372
27.

Decreased T3 and T4 levels following topical application of povidone-iodine in premature neonates.

AvRuskin TW, Greenfield E, Prasad V, Greig F, Juan CS.

J Pediatr Endocrinol. 1994 Jul-Sep;7(3):205-9.

PMID:
7820214
28.

Neonatal hyponatremic dehydration as an initial presentation of cystic fibrosis.

Greig F, Schoeneman MJ, Kandall SR, Bonforte RJ.

Clin Pediatr (Phila). 1993 Sep;32(9):548-51. No abstract available.

PMID:
8258209
29.

Slipped capital femoral epiphysis during treatment with recombinant growth hormone for isolated, partial growth hormone deficiency.

Prasad V, Greig F, Bastian W, Castells S, Juan C, AvRuskin TW.

J Pediatr. 1990 Mar;116(3):397-9. No abstract available.

PMID:
2308031
30.

Changes in plasma osteocalcin concentrations during treatment of rickets.

Greig F, Casas J, Castells S.

J Pediatr. 1989 May;114(5):820-3. No abstract available.

PMID:
2785593
31.

Severely deficient binding of 1,25-dihydroxyvitamin D to its receptors in a patient responsive to high doses of this hormone.

Castells S, Greig F, Fusi MA, Finberg L, Yasumura S, Liberman UA, Eil C, Marx SJ.

J Clin Endocrinol Metab. 1986 Jul;63(1):252-6.

PMID:
3011841
32.

Percutaneous transluminal renal angioplasty in the treatment of renovascular hypertension in children.

Fallo F, Oberfield SE, Levine LS, Stoner E, Greig F, Sniderman K, Saddekni S, Sos T, New MI.

Clin Exp Hypertens A. 1986;8(4-5):887-91.

PMID:
2944677
33.

Evaluation of percutaneous transluminal renal angioplasty in childhood hypertension.

Fallo F, Oberfield SE, Levine LS, Stoner E, Greig F, New MI, Sniderman K, Saddekni S, Sos T.

Int J Pediatr Nephrol. 1985 Oct-Dec;6(4):261-6.

PMID:
2936692
34.

Duplication 11 (q22----qter) in an infant. A case report with review.

Greig F, Rosenfeld W, Verma RS, Babu KA, David K.

Ann Genet. 1985;28(3):185-8.

PMID:
3879155
35.

Recovery of adrenal function after treatment of adrenocortical carcinoma with o,p'-DDD.

Greig F, Oberfield SE, Levine LS, Ghavimi F, Pang S, New MI.

Clin Endocrinol (Oxf). 1984 Apr;20(4):389-99.

PMID:
6325050
36.

Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess.

Oberfield SE, Levine LS, Carey RM, Greig F, Ulick S, New MI.

J Clin Endocrinol Metab. 1983 Feb;56(2):332-9.

PMID:
6296185
37.

Adrenal glomerulosa function in patients with dexamethasone-suppressible hyperaldosteronism.

Oberfield SE, Levine LS, Stoner E, Chow D, Rauh W, Greig F, Lee SM, Lightner E, Witte M, New MI.

J Clin Endocrinol Metab. 1981 Jul;53(1):158-64.

PMID:
7016891
38.

Altered sexual development in male rats after oestrogen administration during the neonatal period.

Brown-Grant K, Fink G, Greig F, Murray MA.

J Reprod Fertil. 1975 Jul;44(1):25-42.

PMID:
1151930
40.
41.

Effects of steroid hormones on gonadotrophin secretion in female rats after ovariectomy during the oestrous cycle.

Tapper CM, Greig F, Brown-Grant K.

J Endocrinol. 1974 Sep;62(3):511-25. No abstract available.

PMID:
4472097
42.

Changes in the sensitivity of the pituitary gland to luteinizing hormone releasing factor during the oestrous cycle of the rat.

Aiyer MS, Fink G, Greig F.

J Endocrinol. 1974 Jan;60(1):47-64. No abstract available.

PMID:
4591041
43.

Proceedings: A priming effect of luteinizing hormone releasing factor on the anterior pituitary gland in the female rat.

Aiyer MS, Chiappa SA, Fink G, Greig F.

J Physiol. 1973 Oct;234(2):81P-82P. No abstract available.

44.

Preovulatory levels of luteinizing hormone, the critical period and ovulation in rats.

Greig F, Weisz J.

J Endocrinol. 1973 May;57(2):235-45. No abstract available.

PMID:
4735927
45.

Sensitivity of the anterior pituitary gland to luteinizing hormone releasing factor (LRF) during pro-oestrus in the rat.

Aiyer MS, Fink G, Greig F.

J Physiol. 1973 May;231(1):32P-34P. No abstract available.

46.

Induced ovulation in albino rats exposed to constant light.

Brown-Grant K, Davidson JM, Greig F.

J Endocrinol. 1973 Apr;57(1):7-22. No abstract available.

PMID:
4735633
47.

Serial luteinizing hormone measurements in cannulated, unanesthetized rats.

Greig F.

J Physiol. 1971 Oct;218 Suppl:29P-30P. No abstract available.

48.

Seasonal changes in the adenohypophysis of the bank vole, Clethrionomys glareolus.

Clarke JR, Greig F.

J Reprod Fertil. 1971 May;25(2):310-1. No abstract available.

PMID:
5558400

Supplemental Content

Support Center